Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 11;12(1):21421.
doi: 10.1038/s41598-022-26087-0.

Qualitative and quantitative phytochemical screening of Nerium oleander L. extracts associated with toxicity profile

Affiliations

Qualitative and quantitative phytochemical screening of Nerium oleander L. extracts associated with toxicity profile

Neşe Bakir Çilesizoğlu et al. Sci Rep. .

Abstract

In this study, phytochemical analysis and toxicity profile of leaf and flower extracts of Nerium oleander L. species collected from Giresun province (Turkey) were investigated. In phytochemical analyzes, the cardiac glycoside, alkaloid, saponin and tannin contents of the extracts were analyzed qualitatively and quantitatively. The physiological effects of extracts were determined by examining root elongation, weight gain and germination rates. Biochemical effects were determined by measuring the levels of malondialdehyde (MDA), glutathione (GSH), superoxide dismutase (SOD) and catalase (CAT), which are indicators of oxidative stress. Cytotoxic and genotoxic effects were investigated by mitotic index (MI), micronucleus (MN) and chromosomal abnormality (CA) tests. N. oleander leaf and flower extract applications caused significant decreases in the physiological parameters of Allium bulbs. SOD and CAT activity in root tip cells increased significantly after the application of leaf extract compared to the control group. Similar changes were observed in the application of flower extract, but these increases were found to be at a lower level compared to the increases induced by the leaf extract. An increase in MDA levels and a decrease in GSH levels were observed in groups treated with leaf and flower extracts. These changes show that the extracts cause deterioration in antioxidant/oxidant balance. It was determined that the extracts, which caused a decrease in MI rates and an increase in MN and CAs frequencies, showed the most prominent cytotoxic and genotoxic effects at 250 μg/mL doses. These toxic effects were associated with the phytochemical content of the extracts, and it was thought that cardiac glycosides and alkaloids, whose presence were detected in qualitative and quantitative analyzes, may play an important role in toxicity. Studies investigating the therapeutic properties of plants as well as their toxic effects are insufficient, which leads to the fact that plants exhibiting potential toxicity are not well known. Therefore, this study will lead many studies on the toxicity profile of the phytochemical contents of plants. Therefore, this study will draw attention to the investigation of the toxicity profile and phytochemical contents of plants and will lead to similar studies.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Appearance of N. oleander leaf and flower tissues before and after drying.
Figure 2
Figure 2
Qualitative analysis of Noex-I. S.E and M.E indicate extraction with water and methanol, respectively.
Figure 3
Figure 3
Qualitative analysis of Noex-II. S.E and M.E indicate extraction with water and methanol, respectively.
Figure 4
Figure 4
Quantitative analysis of phytochemicals in Noex-I and Noex-II. Cardiac glycoside: mgSE/g, tannin: mgTE/g, saponin mgDE/g, alkaloid: mg AE/g.
Figure 5
Figure 5
The effect of Noex-I and Noex-II applications on SOD and CAT activities. Group I: Control, Group II: 50 μg/mL Noex-I, Group III: 100 μg/mL Noex-I, Group IV: 250 μg/mL Noex-I, Group V: 50 μg/mL Noex-II, Group VI: 100 μg/mL Noex-II, Group VII: 250 μg/mL Noex-II. *Indicates the statistical difference between Group I and IV, **Indicates the statistical difference between Group I and VII (p < 0.05).
Figure 6
Figure 6
The effect of Noex-I and Noex-II applications on MDA and GSH levels. Group I: Control, Group II: 50 μg/mL Noex-I, Group III: 100 μg/mL Noex-I, Group IV: 250 μg/mL Noex-I, Group V: 50 μg/mL Noex-II, Group VI: 100 μg/mL Noex-II, Group VII: 250 μg/mL Noex-II. *Indicates the statistical difference between Group I and IV, **Indicates the statistical difference between Group I and VII (p < 0.05).
Figure 7
Figure 7
The effects of Noex-I and Noex-II applications on MI(%) and MN frequencies. Group I: Control, Group II: 50 μg/mL Noex-I, Group III: 100 μg/mL Noex-I, Group IV: 250 μg/mL Noex-I, Group V: 50 μg/mL Noex-II, Group VI: 100 μg/mL Noex-II, Group VII: 250 μg/mL Noex-II.
Figure 8
Figure 8
Appearances of MN and CAs induced by Noex-I. MN (a), nuclear bud (b), vagrant chromosome (c), bridge (d), unequal distribution of chromatin (e), sticky chromosome (f), fragment (g), vacuolated nucleus (h).
Figure 9
Figure 9
Appearances of MN and CAs induced by Noex-II. MN (a), nuclear bud (b), vagrant chromosome (c), bridge (d), unequal distribution of chromatin (e), sticky chromosome (f), fragment (g), vacuolated nucleus (h).
Figure 10
Figure 10
Anatomical changes induced by Noex-I. Normal appearance of epidermis cells (a), normal appearance of cell nucleus-oval (b), normal appearance of cortex cells (c), normal appearance of vascular tissue (d), epidermis cell damage (e), flattened cell nucleus (f), giant cell nucleus (g), binuclear cell (h), cell with MN (i), cortex cell damage (j), cortex cell wall thickening (k), indistinct vascular tissue (i).
Figure 11
Figure 11
Anatomical changes induced by Noex-II. Normal appearance of epidermis cells (a), epidermis cell damage (b), normal appearance of cell nucleus-oval (c), flattened cell nucleus (d), cell with MN (e), normal appearance of cortex cells (f), cortex cell damage (g), thickening of the cortex cell wall (h), normal appearance of vascular tissue (i), indistinct vascular tissue (j).

Similar articles

Cited by

References

    1. Leicach SR, Chludil HD. Plant secondary metabolites: Structure–activity relationships in human health prevention and treatment of common diseases. Stud. Nat. Prod. Chem. 2014;42:267–304. doi: 10.1016/B978-0-444-63281-4.00009-4. - DOI
    1. Twaij BM, Hasan MN. Bioactive secondary metabolites from plant sources: Types, synthesis, and their therapeutic uses. Int. J. Plant Biol. 2022;13(1):4–14. doi: 10.3390/ijpb13010003. - DOI
    1. Veeresham C. Natural products derived from plants as a source of drugs. J. Adv. Pharm. Technol. Res. 2012;3(4):200. doi: 10.4103/2231-4040.104709. - DOI - PMC - PubMed
    1. Bhutani KK, Gohil VM. Natural products drug discovery research in India: Status and appraisal. Indian J. Exp. Biol. 2010;48:199–207. - PubMed
    1. Kumar A, De T, Mishra A, Mishra AK. Oleandrin: A cardiac glycosides with potent cytotoxicity. Pharmacogn. Rev. 2013;7(14):131–139. doi: 10.4103/0973-7847.120512. - DOI - PMC - PubMed